ArticleNeuroradiology2019
Why is middle cerebral artery plaque augmented by contrast media? A phantom study using middle cerebral artery stenotic silicon model.
Article in Neuroradiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 2 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
Abstract
purposeThe pathophysiologic mechanisms of contrast enhancement (CE) of middle cerebral artery (MCA) plaque remain unclear since histologic and imaging findings have never been compared. The purpose of this study was to assess the pattern of CE between patients with MCA stenosis or occlusion and in an MCA stenotic silicone model.
methodsWe retrospectively reviewed black blood (BB) contrast-enhanced T1-weighted (CE-T1W) imaging of patients who presented with acute stroke symptoms between January 2017 and January 2018. We subdivided the enrolled subjects according to whether the cerebral angiography findings suggested stenosis or occlusion. Silicone models were made with 4 degrees of MCA stenosis (stenotic area: 0.8 mm, 1.0 mm, 1.2 mm, and 1.4 mm) with a 3-mm lumen. BB CE-T1W imaging on silicone models with stenosis was obtained 5 min after contrast injection.
resultsDuring the period of this study, 19 patients with complete MCA occlusion and 22 with MCA stenosis, as shown by the cerebral angiography, were enrolled in this study. The CE of the silicone models with stenosis were 0.8 (74%) mm and 1.0 (66.7%) mm. The SI ratios of the CE of the plaque and the lumen were similar between the silicone models and the MCA stenosis/occlusion groups (silicone models: 31.0 ± 11.2; MCA occlusion: 27.6 ± 19.6; MCA stenosis: 22.8 ± 9.8).
conclusionThe silicone stenotic MCA model was characterized by luminal enhancement through contrast stagnation. The findings of the CE of the MCA plaque may be partially associated with stagnation of the contrast media.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.